Objective To investigate the control target of intact parathyroid hormone (iPTH) level in patients with non-dialysis-dependent chronic kidney disease (CKD). Methods The CKD patients with complete blood and urine biochemical results, not received renal replacement therapy and treated in the Outpatient/Inpatient Sections, Department of Nephrology, Peking University People's Hospital from March 2016 to October 2022 were recruited. The relationship between estimated glomerular filtration rate (eGFR), iPTH and fraction excretion of phosphate (FEP) in these patients were investigated. By using the segment function in R language, the iPTH-FEP fitting curve is depicted to find out the truncate point that FEP increases no longer with the increase of iPTH. Results A total of 125 subjects were enrolled in this study. When eGFR was <60 ml / min·1.73m2, iPTH and FEP levels gradually increased with the decline of renal function. When iPTH >114.74pg/ml, FEP no longer increased. Conclusion When iPTH increased to more than 114.74pg/ml in non-dialysis-dependent CKD patients, the ability to promote renal excretion of phosphorus reached the maximum.
DU Chen-Lu
,
ZUO Li
,
WANG Qing-Hua
,
ZHU Hui-Min
,
JIAO Xia
. Clinical study on the relationship between stage of chronic kidney disease, parathyroid hormone and urinary phosphorus excretion fraction[J]. Chinese Journal of Blood Purification, 2023
, 22(08)
: 599
-603
.
DOI: 10.3969/j.issn.1671-4091.2023.08.007
[1]Streja E, Lau WL, Goldstein L,et al.Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Kidney Int Suppl(2011).2013 Dec; 3(5):462-468.
[2]国家肾脏疾病临床医学研究中心.中国慢性肾脏病矿物质和骨异常诊治指南概要[J].肾脏病与透析肾移植杂志, 2019, 28(1):27-57
[3]Evenepoel P, Bover J, Urena Torres P.Parathyroid hormone metabolism and signaling in health and chronic kidney disease[J].Kidney Int, 2016, 90(6):1184-1190
[4]张昆, 路燕燕, 刘熹, 余晨.血磷正常的慢性肾脏病患者矿物质骨代谢异常的相关性因素分析[J].世界临床医学, 2018, 12(1):1-3
[5]Craver L，Marco MP，Martinez I, et al.Mineral metabolism parameters throughout chronic kidney disease stages 1-5-achivevement of KDOQI target ranges[J].Nephrol Dial Transplant, 2007, 22(4):1171-1176
[6]Vassalotti JA, Uribarri J, Chen SC, et al.Trends in mineral metabolism:Kidney Early Evaluation Program(KEEP) and the National Health and Nutrition Examination Survey (NHANES)1999-2004[J].Am J Kidney Dis, 2008, 51(4 Suppl 2):S56-58
[7]Fukagawa M, Yokoyama K, Koiwa F, et al.Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder[J].Ther Apher Dial, 2013, 17(3):247-288
[8]Fukagawa M, Kazama J, Shigematsu T.Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases[J].American Journal of Kidney Diseases, 2001, 38(4):S152-S155
[9]高志红.钙、磷、镁的代谢[J].中国医刊, 2002, 37(11):6-7
